CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | McKee Amy E Director | Sale | −11,180 | $8.97 | $100K | 31,252 |
| 2026-05-13 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −62,500 | $9.54 | $596K | 400,703 |
| 2026-03-20 | HEGGIE THERESA Director | Sale | −49,933 | $10.11 | $505K | 65,352 |
| 2026-03-16 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −150,000 | $9.15 | $1.4M | 400,703 |
| 2025-12-22 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −21,773 | $7.65 | $167K | 398,751 |
| 2025-12-15 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −21,210 | $7.65 | $162K | 315,726 |
| 2025-12-03 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −19,770 | $7.65 | $151K | 345,476 |
| 2025-12-02 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −50,906 | $7.21 | $367K | 365,246 |
| 2025-12-01 | Barnes Alane P Chief Legal Officer | Sale 10b5-1 | −91,004 | $7.10 | $647K | 416,152 |
| 2025-11-13 | SANDERS MACHELLE Director | Sale 10b5-1 | −9,600 | $7.14 | $69K | 30,642 |
| 2025-08-13 | HEGGIE THERESA Director | Sale | −70,000 | $8.51 | $596K | 65,352 |
| 2024-12-13 | Hutson Nancy J Director | Sale 10b5-1 | −7,000 | $7.54 | $53K | 86,638 |
| 2024-06-24 | McKee Amy E Director | Sale | −8,600 | $6.32 | $54K | 27,831 |
| 2024-06-17 | SANDERS MACHELLE Director | Sale | −4,689 | $6.00 | $28K | 27,742 |
| 2024-06-14 | HEGGIE THERESA Director | Sale | −6,698 | $6.11 | $41K | 52,852 |
| 2023-06-15 | SANDERS MACHELLE Director | Sale | −4,000 | $7.98 | $32K | 25,611 |
| 2023-06-14 | Hutson Nancy J Director | Sale | −12,866 | $8.04 | $103K | 81,818 |
| 2023-04-03 | Thackray Helen M. Chief R&D Officer | Sale 10b5-1 | −7,000 | $8.29 | $58K | 207,275 |
| 2023-02-01 | Stonehouse Jon P President & CEO | Sale | −100,000 | $10.38 | $1.0M | 1,008,739 |
| 2022-12-15 | Stonehouse Jon P President & CEO | Sale | −14,100 | $10.90 | $154K | 887,730 |
Page 1 of 2 · 37 trades